Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks

Jul 06, 2026

Posted by Pharvaris, Inc.

June Update: Antibody Industry Trends (Q2 2026 Insights, Trends & Analysis)

Jul 02, 2026

Posted by Biointron Biological

Cilcare Doubles Down on Hearing Loss: Updates License Deal with Sanofi who becomes equity holder

Jun 25, 2026

Posted by Cilcare

NEW: Introducing RushData 🚀

Jun 19, 2026

Posted by Biointron Biological

J Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment

Jun 17, 2026

Posted by Uniphar

Chronic Disease Day Luncheon at MassBio Hub

Jun 16, 2026

Posted by Good Days